Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Dome Energy resumes drilling program in Orangefield, Texas

Dome Energy AB.  (herein after “Dome” and/or “the Company”) today announces that they resumes the drilling program in Orangefield, Texas. ·  Program in Orangefield with a planned drilling start in March for the two first wells ·  Hager # 39 and # 40 are planned to be drilled to a depth of 5,000 ft ·  Estimated investment $550,000 per well ·  The first two of more than 20 possible wells to be drilled in Orangefield Paul Morch, CEO: “It is with the great pleasure to announce that we are resuming our drilling program in Orange Field, which initially

Healthcare start up Nightingale invited to solve world’s biggest health problem with the UN and MIT

Nightingale Health’s blood analysis technology has been chosen from hundreds of applications to be presented at the Solve pitch event at United Nations headquarters in March. Solve is a program led by MIT seeking solutions for the world's most challenging problems: refugee education, carbon emissions and in this case, chronic diseases. Nightingale Health is a pioneering healthcare company. Their unique solution was chosen as one of 15 finalists in the chronic diseases challenge. Nightingale’s revolutionary technology provides detailed biological data from a single blood sample. This

Pioneering Healthcare Company changes name from Brainshake to “Nightingale Health”

After three years of fast growing business in the medical research market, the company known as Brainshake has unveiled its new company name, Nightingale Health. This coincides directly with the company’s move in 2017 to clinical testing in Europe. With its unique, proprietary and powerful blood testing re-invention, Nightingale aims to solve the world’s biggest health problem. The technology has been proven to advance research in chronic diseases such as heart disease and diabetes, and is supported by over 100 peer-reviewed biomedical publications. When asked about the new name, CEO Teemu

Resurs Bank issues SEK 300 million of senior unsecured bonds

Resurs Bank AB (publ), a wholly owned subsidiary of Resurs Holding AB (Nasdaq Stockholm: RESURS), has issued SEK 300 million of senior unsecured bonds in the Nordic market. The bonds have a maturity of 3 years and will be listed at Nasdaq Stockholm. The 3-year bonds are issued under Resurs Bank's MTN programme (total frame of SEK 3 billion) with a coupon of 3m Stibor +1.55%. Trade date is 16 February 2017. Nordea Bank AB has been used as bookrunner. Transaction details: Issuer: Resurs Bank AB (publ)  Instrument: Senior unsecured bonds  Maturity: 24 February 2020   Coupon: 3

Resurs Bank issues SEK 300 million of senior unsecured bonds

Resurs Bank AB (publ), a wholly owned subsidiary of Resurs Holding AB (Nasdaq Stockholm: RESURS) has issued SEK 300 million of senior unsecured bonds in the Nordic market. The bonds have a maturity of 3 years and will be listed on Nasdaq Stockholm. The 3-year bonds are issued under Resurs Bank's MTN programme (total frame of SEK 3 billion) with a coupon of 3m Stibor +1.55%. Trade date 16 February 2017 and Nordea Bank AB has been used as bookrunner. Transaction details: Issuer: Resurs Bank AB (publ)  Instrument: Senior unsecured bonds  Maturity: 24 February 2020   Coupon: 3

Full Year Report January – December 2016

· Sales increased by 6 percent to 3,957 MSEK (3,719) for the fourth quarter and by 7 percent to 15,551 MSEK (14,486) for the full year. In local currencies, sales increased by 3 percent for the fourth quarter and by 7 percent for the full year. · Operating profit from product areas1) increased by 5 percent to 954 MSEK (908) for the fourth quarter and by 8 percent to 3,990 MSEK (3,690) for the full year. In local currencies, operating profit from product areas1) was flat for the fourth quarter and increased by 8 percent for the full year. · Operating profit2) amounted to 954 MSEK (908)

Strong finish to a new record year

“When we set new targets for Ework’s onward growth journey at the beginning of last year, we aimed high. We can now look back on a 2016 when we beat our targets, with continued high sales growth and increasing earnings per share. We also continued to invest in our future.” Extract from CEO Zoran Covic’s commentary to the Year-end Report.Fourth quarter 2016 compared to the corresponding period 2015 · Net sales increased by 33% to SEK 2,320 M (1,741). · Operating profit up by 33% to SEK 29.3 M (22.0). · Order intake amounted to SEK 3,917 M (2,949), in the fourth quarter, a 33%

Arise announces a fully supported rights issue of convertible bonds to proactively develop its position and strengthen its financial flexibility.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, JAPAN, HONG KONG, SINGAPORE, SOUTH AFRICA, NEW ZEALAND, AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.Pursuant to the authorisation of the General Meeting held on 3 May 2016, the Board of Directors of Arise AB (publ) (“Arise” or “the Company”) decided on 17 February 2017 that the Company is to raise a convertible loan of a nominal maximum of approximately MSEK 245 with

D. Carnegie & Co invites to an audiocast in connection with publication of the year-end report 2016

D. Carnegie & Co AB (publ) – listed on Nasdaq Stockholm – invites to an audiocast at 10.00 am on February 24, in connection with the publication of its year-end report 2016, which will be published that day at 7.00 am.Shareholders, analysts and other interested parties are welcome to participate in an audiocast in which the financial report for the fourth quarter will be presented by CEO Ulf Nilsson and CFO Per-Axel Sundström. The presentation and related material will be accessible through www.dcarnegie.se and can be followed via web or by telephone on the numbers provided below. Kindly

Interim Report January 1 – December 31, 2016

All-time high Sales for a quarter and the first shipment of our new product Nevisense ViewThe fourth quarter in figures · Net sales amounted to TSEK 1,935 (1,181). · The loss after tax amounted to TSEK 14,623 (11,154). · The loss per share amounted to SEK 1.77 (1.35). · The cash flow from current operations was negative in the amount of TSEK 13,032 (13,864). · Significant margin improvement with gross margin increasing to 35.0% in Q4 (18.4%). The full year in figures · Net sales amounted to TSEK 6,436 (4,151). · The loss after tax amounted to TSEK 53,086 (41,532).

Kraken FPSO in the field and hooked up

ENQUEST PLC, 17 February 2017Development update: Kraken FPSO in the field and hooked up The Kraken development The Kraken Floating Production Storage and Offloading ('FPSO') vessel arrived at the field on Monday 13 February, anticipating good weather conditions. The hook up of the Submerged Turret Production ('STP') buoy mooring system, to the FPSO was completed on 15th February and a full rotation test performed so that the vessel is now on station and securely moored. Commissioning work will continue on the topsides. Reconstruction of the turret area pipework and connection of the

Alligator Bioscience AB Full Year 2016 Report

Summary · During the quarter were the company’s shares listed for trading on Nasdaq Stockholm Mid Cap. In connection with this were new shares issued that provided the company 350 000 TSEK before underwriting expenses. · The company's project portfolio has continued to develop according to plan including the start of dosing in a second phase I clinical trial that is done by Janssen Biotech. · The Board of Directors proposes that no dividend shall be paid for the year 2016. Conference call for investors, analysts and the mediaThe 2016 Financial Statement will be presented by

Bonava acquires land and creates neighbourhood with 200 housing units in Uppsala

Bonava has concluded an agreement for the acquisition of the Broccolin property block from Gillöga AB. The property is located between Årsta Torg and Årsta Park in the Östra Salabacke development area. The detailed development plan has gained legal force.- I am pleased that we can expand our project and development rights portfolio in a prime residential location in Uppsala. The acquisition is in line with our strategy of developing homes and happy neighbourhoods where people have the highest quality of life, says Fredrik Hemborg, Business Unit Manager, Bonava Sweden. The property is

Ovako inaugurates SEK 300 million investment in Hofors

Over the past ten years Ovako has invested around SEK 300 million in Hofors to address customer demand for heavier and larger rings. The new production process was inaugurated on February 16 by Gävleborg’s County Governor Per Bill and the President of Ovako in Hofors, Carl-Michael Raihle.The need for larger bearings is growing worldwide as investment is made in more and bigger wind turbines. To meet this demand, Ovako in Hofors is now investing in larger ingots, doubling their size. This makes it possible to produce bearing rings with a diameter in excess of four meters and up to five tons

Read original

Year-end report 1 January – 31 December 2016

Fourth quarter (1 October – 31 December 2016) · Net sales for the quarter amounted to MSEK 290 (151). · Operating profit before depreciation and amortisation (EBITDA) was MSEK 61 (48), of which associates had an impact of MSEK 0 (-19) on the Group. Operating cash flow was MSEK 38 (28). · Profit/loss before tax totalled MSEK 12 (-4), including non-recurring effects of MSEK 0 (-37). · Profit/loss after tax totalled MSEK 10 (-4), corresponding to SEK 0.30 (-0.11) per share. · Production totalled 238 GWh (228), of which 128 GWh (125) pertained to Own wind power operations and

Lynparza positive in metastatic BRCA breast cancer

This announcement contains inside information 17 February 2017, 07:00 GMT LYNPARZA MEETS PRIMARY ENDPOINT IN PHASE III TRIAL IN BRCA-MUTATED METASTATIC BREAST CANCER Lynparza provided a statistically-significant improvement in progression-free survival compared to chemotherapy First positive randomised trial to evaluate the efficacy and safety of a PARP inhibitor beyond ovarian cancer AstraZeneca today announced positive results from its Phase III OLYMPIAD trial comparing Lynparza (olaparib) tablets (300mg twice daily) to physician's choice of a standard of care chemotherapy

Ratos: Year-end report 2016

PRESS  RELEASE  17 February 2017 This information is information that Ratos AB is obliged to make public pursuant to the EU Market Abuse Regulation.The information was submitted for publication, through the agency of the contact person set out above, at 8.00 CET on 17 February 2017. Development in company portfolio · Sales growth +13%. Adjusted for the size of Ratos's holding, net sales amounted to SEK 22,794m (20,164) · Adjusted EBITA development -2%, adjusted for Ratos's holding, mainly due to weak performance of GS-Hydro. The portfolio's adjusted EBITA amounted to SEK 1,

Konecranes Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

Konecranes  has on February 16, 2017, received a notification under Chapter 9, Section 5 of the Securities Market Act, according to which the total holding of BlackRock, Inc. in Konecranes Plc’s shares and votes has exceeded 5 percent. On February 15, 2017, Blackrock Inc.’s total holding through shares and financials instruments amounted to 8.25 percent of Konecranes Plc’s shares and votes.Total positions of BlackRock, Inc.:    % of % of shares Total of Total number of shares shares and voting both in % and voting rights of

CLX Communications AB (publ): Year-End Report, July 2015 - December 2016

Sixth quarter, October - December 2016 · Net sales increased by 145 percent to SEK 669.6 million (273.5). Organic growth was 35 percent. · EBITDA amounted to SEK 68.1 million (27.9). · EBITDA excluding items affecting comparability[ 1] (adjusted EBITDA) amounted to SEK 76.0 million (29.4). · EBIT amounted to SEK 46.5 million (26.0). · Net profit for the quarter amounted to SEK 53.2 million (20.0). · Diluted earnings per share amounted to SEK 1.09 (0.53). July 2015 - December 2016 · Net sales increased by 53 percent to SEK 2,333.9 million (1,361.1).

Tieto new Data-Driven Businesses unit aims to bring Artificial Intelligence to healthcare

Tieto is actively investigating new cutting-edge technologies, like Artificial Intelligence and their opportunities in various sectors. In healthcare AI can be utilized to get human centric and data-driven health and wellbeing services. To further strengthen its open partner ecosystem and presence in the Nordic healthcare sector, Tieto is joining the Microsoft AI in Health Partner Alliance. As part of its participation, Tieto will receive unique training and exclusive access to Microsoft technologies, engineering expertise and data sets.Tieto’s newly established Data-Driven Businesses wants

YEAR-END REPORT JANUARY–DECEMBER 2016

Another strong year THE QUARTER OCTOBER–DECEMBER 2016 • Rental income amounted to MSEK 684 (624)   • Profit from property management totaled MSEK 537 (405), corresponding to SEK 3.23 per ordinary share (2.78)    • Profit after tax amounted to MSEK 837 (573), corresponding to SEK 5.02 per ordinary share (3.99)    • Cash flow from operating activities before changes in working capital was MSEK 321 (290), corresponding to SEK 1.86 per ordinary share (1.92) FULL-YEAR 2016 • Rental income amounted to MSEK 2,642 (2,443) • Profit from property management totaled MSEK 1,812 (

BJÖRN BORG AB YEAR END-REPORT JANUARY – DECEMBER 2016

1 OCTOBER – 31 DECMEBER, 2016              · The Group’s net sales increased by 12.3 percent to SEK 171.4 million (152.6). Excluding currency effects, sales rose by 10.2 percent. · The gross profit margin was 48.0 percent (51.8). Excluding currency effects, the margin was 49.9 percent. · Operating profit amounted to SEK 21.4 million (14.6). · Profit after tax was SEK 17.9 million (7.3). · Earnings per share before and after dilution amounted to SEK 0.74 (0.34). 1 JANUARY – 31 DECEMBER, 2016 · The Group’s net sales increased by 10 percent to SEK 631.6 million (574.3).

CLX Communications AB (publ) acquires German technology company Xura Secure Communications GmbH

Stockholm, Sweden - CLX Communications AB (publ.) - XSTO:CLX CLX Communications, a leading global provider of cloud-based communication services, announces that it has acquired the German technology company Xura Secure Communications GmbH, a subsidiary of Xura Inc. "CLX was founded on a vision to become the world's largest and leading player in the market for mobile cloud-based communications, with solutions for text, voice and Internet of Things - IOT. Following the IPO in October 2015, the acquisitions in 2016 of Mblox and Sinch AB, and now the acquisition of Xura Secure

There are no items matching the current filter
There are no more items matching the current filter
Back to top